We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.

Schedule an appointment today

Pediatric Hematology Oncology Clinical Trials Unit

Pediatric Hematology Oncology Clinical Trials Unit

As an academic medical center at UH Rainbow Babies & Children's, we are steadfast in our commitment to advance medical treatment and improve outcomes for patients of all ages diagnosed with cancer or blood disorders.

Learn More

To learn more about pediatric cancer and blood disorder clinical trials, email PHOCTU@uhhospitals.org

Browse Clinical Trials & Studies

The clinical trials and research projects at UH Rainbow Babies and Children’s Pediatric Hematology Oncology Clinical Trial Unit (CTU) aim to answer the various questions surrounding childhood cancer and bleeding disorders.

In 2021, the CTU was created in response to the challenges and nuances associated with pediatric research trials. Just as our patients require specialized skilled care, so do the numerous clinical trials conducted within the CTU. The clinical trials unit was founded on this belief.

Sanjay Ahuja, MD and Kristin Leuchtag, JD., lead the CTU team which includes physicians, advanced care providers, research nurse coordinators, regulatory specialists, data managers, and research specialists, who conduct and support the Pediatric Hematology Oncology research portfolio.

The CTU offers assistance in regulatory services, study coordinator services, clinical staffing, FDA submission and management, data entry and management.


Our Research by the Numbers 

Over

100
current clinical trials
3x
increase in research faculty since 2020

National & International Collaborations Create Care Initiatives

With experience in conducting all categories of research, many of our researchers frequently work with outside groups to collaborate on national and international care initiatives.

Investigator Initiated Trials

Investigator-initiated Trials (IIT), sometimes referred to as Investigator-Initiated Studies (IIS) are studies conceived, planned, and conducted by the Research Physicians at Rainbow Babies and Children’s. These studies can include all types of research.

Industry Trials

Industry sponsored research is paid for by an organization that has contracted with Rainbow Babies and Children’s to conduct a clinical trial. For most industry-sponsored clinical trials, the industry organization designs the study and owns the protocol.

Children’s Oncology Group

The Children’s Oncology Group (COG), a National Cancer Institute-supported member group of the National Clinical Trials Network, is the world’s largest, cooperative children’s cancer research entity. With over 10,000 members, it brings together physicians, laboratory scientists, nurses, psychologists and others working to beat cancer in children, adolescents and young adults at more than 200 leading children’s hospitals, universities, and cancer centers across North America, Australia, and New Zealand. The tremendous progress that has taken place in developing successful treatments for childhood cancer has been made possible through research. The Children’s Oncology Group research has turned children’s cancer from a virtually incurable disease 50 years ago to one with a combined 5-year survival rate of 80 percent today. For more than 50 years, the Pediatric Hematology Oncology team at Rainbow Babies and Children’s has been an active member of COG and continues to provide support for these pivotal research trials.